Filing Details

Accession Number:
0000711377-20-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-04 14:40:26
Reporting Period:
2020-11-02
Accepted Time:
2020-11-04 14:40:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912
Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-02 800 $35.34 14,270 No 4 M Direct
Common Stock Disposition 2020-11-02 800 $70.55 13,470 No 4 S Direct
Common Stock Acquisiton 2020-11-03 6,666 $35.34 20,136 No 4 M Direct
Common Stock Disposition 2020-11-03 6,666 $70.54 13,470 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2020-11-02 800 $0.00 800 $35.34
Common Stock Common Stock (Right to Buy) Disposition 2020-11-03 6,666 $0.00 6,666 $35.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
147,998 2020-10-08 2020-11-08 No 4 M Direct
141,332 2020-10-08 2020-11-08 No 4 M Direct